Safety Profile Following Td Vaccination in Indonesian Pregnant Woman
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years to 39 Years (Adult)
Sexes Eligible for Study:
Gender Based Eligibility:
Gender Eligibility Description:
Accepts Healthy Volunteers:
200 pregnant woman, 18-39 years old From provincial health primary center
Healthy Pregnant Woman aged 18-39 years old
27-36 weeks of pregnancy
Subject have been informed properly regarding the study and signed the informed consent form
Subject will commit to comply with the instructions of the investigator and the schedule of the trial
Given simultaneously with other vaccines or with the interval less than 1 month with other vaccination